Evidence map›Paper›PMID 42432367›Full record

ArticleJournal of computer-aided molecular design2026

N-aryl oleamides derived from indonesian palm oil as anticancer agents: from in silico design to synthesis and in vitro assay.

Jumina, Umi Nurwahidah, Yehezkiel Steven Kurniawan, Robby Noor Cahyono, Ervan Yudha, Naresh Kumar, Bambang Purwono, Eti Nurwening Sholikhah

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

JuminaDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia. jumina@ugm.ac.id.
Umi NurwahidahDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Yehezkiel Steven KurniawanDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Robby Noor CahyonoDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Ervan YudhaDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Naresh KumarSchool of Chemistry, The University of New South Wales, Sydney, Australia.
Bambang PurwonoDepartment of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Eti Nurwening SholikhahDepartment of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Funding

Lembaga Pengelola Dana Pendidikan 4301/B3/DT.03.08/2025 and 10107/UN1.P/Dit-Keu/HK.08.00/2025
6 · The paper itself

Abstract

Fatty acid synthase (FASN) is overexpressed in many cancers and has therefore emerged as a potential target for anticancer drug development, particularly through inhibition of the thioesterase domain. In this study, 21 N-aryl oleamide derivatives were rationally designed and screened via molecular docking against the thioesterase (TE) domain of FASN. N-phenyloleamide (OA2) and N-(o-tolyl)oleamide (OA3) emerged as the top candidates and were further evaluated in their epoxidized forms: 8-(3-octyloxiran-2-yl)-N-phenyloctanamide (EOA2) and 8-(3-octyloxiran-2-yl)-N-(o-tolyl) octanamide (EOA3). The epoxide derivatives exhibited enhanced binding affinities (OA2 = - 5.49, OA3 = - 5.36, EOA2 = - 5.85, and EOA3 = - 5.84 kcal/mol), with EOA2 showing interactions with the catalytic triad (Ser2308, Asp2338, His2481), suggesting a favorable binding orientation. The selected compounds (OA2, OA3, EOA2, and EOA3) were synthesized and evaluated for cytotoxic activity. EOA2 demonstrated the most potent activity against HeLa cells (IC

Indexed as

Antineoplastic AgentsFatty Acid SynthasesPalm OilAnimalsDrug DesignFatty Acid Synthase, Type IHumansMolecular Docking SimulationMolecular Dynamics SimulationAntineoplastic AgentsFASN protein, humanFatty Acid SynthasesFatty Acid Synthase, Type IPalm OilDrug designEpoxideFatty acid synthaseMolecular dynamicsOleamide

Identifiers

PMID42432367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.